Acessibilidade / Reportar erro

Preformulation studies for the development of a microemulsion formulation from Ambrosia peruviana All., with anti-inflammatory effect

Abstract

Natural products are considered an important source of the therapeutic arsenal currently available. Among these alternatives are the seeds of Ambrosia peruviana (altamisa), whose extract has shown an anti-inflammatory effect. The main objective of this work was to perform a preformulation study of Ambrosia peruviana seeds ethanolic extract, where the main factors that affect the physical, chemical, and pharmacological stability of the extract were evaluated, as well as a compatibility study by differential scanning calorimetry (DSC) analysis against different excipients. A dry extract was obtained by rotary evaporation of the seeds macerated with 96% ethanol. The anti-inflammatory activity was determined by measuring its effect on NO production in RAW 264.7 macrophages, stimulated with LPS. The results showed that the dry extract maintained its stability over time when stored at a temperature of 4 and 25ºC, demonstrating its biological activity, the content of phenolic compounds, and its physicochemical parameters remain practically invariable. However, when exposed to high temperatures (60 ºC) it was affected. The thermal analysis revelated that the behavior of most of the selected excipients and the dry extract was maintained, which indicates that it did not present incompatibilities, therefore they can be candidates for formulating a microemulsion.

Keywords:
Ambrosia peruviana; Preformulation; Stability test; Excipient compatibility study; Microemulsion

INTRODUCTION

Nowadays a large part of the research aimed at the development of new and powerful therapeutic agents is focused on the study of plants used in traditional medicine. In fact, in defining what is considered a drug derived from a natural product, it is estimated that between 25-50% of pharmaceutical products currently used are derived from natural products (Kingston, 2010Kingston DG. Modern natural products drug discovery and its relevance to biodiversity conservation. J Nat Prod. 2010;74(3):496-511.). Those products have taken hold in the market because the population believes that they have fewer adverse effects than synthetic drugs. The WHO recognizes their great relevance in primary care programs since they represent effective alternatives to prevent or treat several diseases (OMS, 2013Organización Mundial de la Salud (OMS), Estrategias de la OMS sobre medicina tradicional 2014-2023. Ginebra; 2013.).

Colombia is a country with a wide variety of ecosystems, ranking among the fourteen countries with the highest biodiversity index, with a fundamental role in sustaining living beings and also representing a source with excellent research potential, making use of plants for the development of new products, such as phytopharmaceuticals (Andrade, 2011Andrade MG. Estado del conocimiento de la biodiversidad en Colombia y sus amenazas. Consideraciones para fortalecer la interacción ciencia-política. Rev Acad Colomb Cienc Exactas Fis Nat. 2011;35(137):491-508.), especially those that present a high demand, such as phytopharmaceuticals with anti-inflammatory activity. The high demand for compounds with this activity is because many studies carried out in recent decades have established a clear relationship between the inflammatory response and the physiopathology of chronic non-transmissible diseases (Pan, Lai, Ho, 2010Pan MH, Lai CS, Ho CT. Anti-inflammatory activity of natural dietary flavonoids. Food Funct. 2010;1(1):15-31.; Prasad, Sung, Aggarwa, 2012Prasad S, Sung B, Aggarwal BB. Age-Associated chronic diseases require age-old medicine: role of chronic inflammation. Prev Med. 2012;54(Suppl):S29-37.). The inflammation in these diseases may appear to different degrees and could be associated with different factors such as age, genre, genetic susceptibility, and modifiable risk factors related to lifestyle (Medzhitov, 2008Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454(7203):428-35.; Meetoo, 2008Meetoo D. Chronic diseases: the silent global epidemic. Br J Nurs. 2008;17(21):1320-5.). The most clinically meaningful drugs for the treatment of these diseases are steroids and non-steroidal anti-inflammatory drugs (NSAIDs), which have a high incidence of side effects. (Nagai et al., 2017Nagai J, Uesawa Y, Shimamura R, Kagaya H. Characterization of the adverse effects induced by acetaminophen and nonsteroidal anti-inflammatory drugs based on the analysis of the japanese adverse drug event report database. Clin J Pain. 2017;33(8):667-75.; Vonkeman, Van de Laar, 2010Vonkeman HE, Van de Laar MAFJ. Nonsteroidal anti-inflammatory drugs: adverse effects and their prevention. Semin Arthritis Rheum. 2010;39(4):294-312.). These reasons have encouraged the search for promising, safer, and more effective substances to treat diseases involving inflammation.

Ambrosia peruviana (Asteraceae), is an aromatic plant, used in traditional medicine in several South American countries for the treatment of different diseases that cause inflammation such as: colic, chronic pain, arthritis, spasms, and infections, among others. (Cicció, Chaverri, 2015Cicció JF, Chaverri C. Essential oil composition of Ambrosia cumanensis (Asteraceae) from Costa Rica. Am J Essent Oils Nat Prod. 2015;3(2):15-21.; Jimenez-Usuga et al., 2016Jimenez-Usuga NDS, Malafronte N, Cotugno R, De Leo M, Osorio E, De Tommasi N. New sesquiterpene lactones from Ambrosia cumanensis Kunth. Fitoterapia. 2016;113:170-4.). In vitro studies on this plant species have shown that the ethanolic extract of seeds has showed significant inhibition on inflammatory markers in RAW 264.7 macrophages stimulated with LPS. (Castro, Franco, Diaz, 2021Castro JP, Franco LA, Diaz F. Anti-inflammatory screening of plant species from the Colombian Caribbean Coast. J Appl Pharm Sci. 2021;11(04):106-17.). Those antecedents make it an important starting point for the development of herbal medicine with anti-inflammatory properties.

The development of a phytopharmaceutical product involves objectives aimed at obtaining a physically and chemically stable, technologically feasible, and biologically available product, for which the concept of “Rational Design of Medicines” must be applied, which in its first stage includes a preformulation study. It is a useful tool in the development of conventional medicines and turn have many elements in common with the preformulation of phytopharmaceuticals (Wyttenbach et al., 2005Wyttenbach N, Birringer C, Alsenz J, Kuentz M. Drug-excipient compatibility testing using a high-throughput approach and statistical design. Pharm Dev Technol. 2005;10(4):499-505.). However, some of these elements are difficult to standardize, due to the complex composition that characterizes these preparations (Bernal, Ramos, Baena, 2019Bernal CA, Ramos FA, Baena Y. Dry powder formulation from Physalis peruviana L. fruits extract with antidiabetic activity formulated via co-spray drying. Int J Appl Pharm. 2019;11(3):109-17.; Matiz, Cárdenas, Rincon, 2007Matiz G, Cárdenas P, Rincon V. Estudios de preformulación de un fitomedicamento tópico antiinflamatorio con base en fracciones activas de flores y hojas de Caesalpinia pulcherrima (L.) Swartz empleando modelos analíticos biológicos. Lat Am J Pharm. 2007;26(3):332.). These studies must be carried out as a stage prior to starting the formulation phase. At this stage, the characterization of the physicochemical properties and the study of the interaction of the extract with possible excipients to be used in the formulation should be performed. At this level, there must be analytical methodologies to be able to ensure the safety, efficacy, and stability of the product in the subsequent stages. In addition, because of the collection of all this information, the guidelines to consider in the implementation of the product manufacturing process in the later stages are obtained (Bernal, Ramos, Baena, 2019Bernal CA, Ramos FA, Baena Y. Dry powder formulation from Physalis peruviana L. fruits extract with antidiabetic activity formulated via co-spray drying. Int J Appl Pharm. 2019;11(3):109-17.; Kopelman, Augsburger, 2002Kopelman SH, Augsburger LL. Excipient compatibility study of Hypericum perforatum extract (St. John’s Wort) using similarity metrics to track phytochemical profile changes. Int J Pharm. 2002;237(1-2):35-46.; Wu et al., 2009Wu Y, Dali M, Gupta A, Raghavan K. Understanding drug-excipient compatibility: oxidation of compound A in a solid dosage form. Pharm Dev Technol. 2009;14(5):556-64.). Considering the panorama previously described, in this work a preformulation study of the ethanolic extract of Ambrosia peruviana seeds was carried out with focus on obtaining a microemulsion for topical use with anti-inflammatory effects.

MATERIAL AND METHODS

Reagents

Ethanol and dimethyl sulfoxide (DMSO) were purchased from Thermo Fisher Scientific (Pittsburgh, PA). Dulbecco’s modified eagle medium (DMEM), lipopolysaccharide from Escherichia coli (LPS), Folin- Ciocalteu, 4-aminobenzenesulfonamide, N-[1,1-naphthyl] ethylenediamine dihydrochloride, sodium nitrite, sodium carbonate, N′-[[3-(aminomethyl)phenyl]methyl] ethanimidamide dihydrochloride (1400W), and gallic acid were obtained from Sigma Aldrich (St Louis, MO). Fetal bovine serum (FBS) from Gibco (São Paulo, Brazil). (Macrophages RAW 264.7 (TIB-71TM) were acquired from the American Type Culture Collection, ATCC. (Manassas, VA). Bromide of 3[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium (MTT) was obtained from Calbiochem (San Diego, CA).

Excipients

Castor oil, vegetable oil and coconut oil supplied by Sigma-Aldrich; sodium laureth sulfate (Sulforokanol® L270/1A) and ceteareth-12 (Rokanol® T12) supplied by PCC Exol; ceteareth-20 (Eumulgin® B2), PEG-150 distearate (Eumulgin® EO 33), poloxamer 188 (Kolliphor® P188), PEG-40 hydrogenated castor oil (Cremophor® RH-40), cocamide DEA (Comperlan® KD), oleth-5 (Eumulgin® O5), PPG-1-PEG-9 lauryl glycol ether (Eumulgin® L), PPG-5-laureth-5 (Eumulgin® ES), PEG-35 castor oil (Kolliphor® EL), [PEG-7 coconutglycerides, PEG-40 hydrogenated castor oil, glycerin, and glyceryl oleate] (Eumulgin® PRO-CL), [MIPA-laureth sulfate, laureth-4 and cocamide DEA] (Plantapon® WW 1000), poloxamer 407 (Kolliphor®P407), [tocopherol and hydrogenated glycerides palm citrate] (Controx® KS C) and EDTA supplied by BASF; polysorbate 80, polyethylene glycol 400, glycerin and propylene glycol supplied by DOW; benzyl alcohol, methylchloroisothiazolinone and methylisothiazolinone (Biosure® MBC) supplied by Petrocarbono.

Plant material

Ambrosia peruviana seeds were collected in Turbana, Bolívar, Colombia (10°24′0″ N, 75°30′0″ O), in July 2018. A voucher specimen of the plant was identified in the herbarium of the Universidad de Antioquia, (Medellin-Colombia) by the biologist Felipe Cardona and deposited with the identification code HUA 214539.

Plant extraction and phytochemical screening

Dried and powdered seeds of A. peruviana were exhaustively extracted with ethanol (96% v/v) by maceration at room temperature (25±3 °C). The extract obtained was dried in a rotary evaporator (Heidolph, Germany) at constant temperature of 40 °C. The dry extract was chemically characterized by the presence of alkaloids, flavonoids, tannins, coumarins, cardiotonic glycosides, saponins, triterpenes/steroids, and quinones. The results were consistent with a previous report (Castro, Franco, Diaz, 2021Castro JP, Franco LA, Diaz F. Anti-inflammatory screening of plant species from the Colombian Caribbean Coast. J Appl Pharm Sci. 2021;11(04):106-17.).

Preformulation study

Stability testing

The reactivity of the extract was evaluated against different conditions, according to the recommendations of the ICH and the WHO on stability studies for drugs (ICH, 2003ICH. Harmonised tripartite guideline, stability testing of new drug substances and products, Q1A(R2). Geneva, Switzerland: ICH; 2003.; WHO, 2008WHO. WHO Expert Committee on specifications for pharmaceutical preparations. Rev Inst Med Trop São Paulo. 2008;50(3):144-144.). Table I specifies the parameters that were considered and the determinations that were made for each of the dry extract samples (Wu et al., 2009Wu Y, Dali M, Gupta A, Raghavan K. Understanding drug-excipient compatibility: oxidation of compound A in a solid dosage form. Pharm Dev Technol. 2009;14(5):556-64.).

TABLE I
Conditions and variables of the stability testing

The dry extract was conditioned in type I amber vial bottles. All the vials were closed, one part of them was stored under refrigeration, another part of them was placed under room temperature conditions and the rest were placed under temperature stress conditions. (See Table I). Each bottle corresponds to one sampling unit. For each of the sampling intervals and conditions, three samples were removed to analyze the response variables in triplicate and have a fourth, in case a re-analysis was needed (Wu et al., 2009Wu Y, Dali M, Gupta A, Raghavan K. Understanding drug-excipient compatibility: oxidation of compound A in a solid dosage form. Pharm Dev Technol. 2009;14(5):556-64.). The response variables established for the study were: organoleptic characteristics, pH, biological evaluation (NO inhibition), and the total phenolic content (TPC) (ICH, 2003ICH. Harmonised tripartite guideline, stability testing of new drug substances and products, Q1A(R2). Geneva, Switzerland: ICH; 2003.; Wu et al., 2009Wu Y, Dali M, Gupta A, Raghavan K. Understanding drug-excipient compatibility: oxidation of compound A in a solid dosage form. Pharm Dev Technol. 2009;14(5):556-64.).

Organoleptic characteristics

Various organoleptic characteristics were considered, such as the appearance, color, smell, and texture of the ethanolic extract of A. peruviana seeds. These characteristics were analyzed in each of the sampling times of the stability study (ICH, 2003ICH. Harmonised tripartite guideline, stability testing of new drug substances and products, Q1A(R2). Geneva, Switzerland: ICH; 2003.; Wu et al., 2009Wu Y, Dali M, Gupta A, Raghavan K. Understanding drug-excipient compatibility: oxidation of compound A in a solid dosage form. Pharm Dev Technol. 2009;14(5):556-64.).

pH

A stock solution of A. peruviana seeds extract (1×105 μg/mL) in DMSO was prepared. A portion of this solution was diluted with deionized water to obtain a solution of 4000 μg/mL; the pH of this solution was measured using an OHAUS starter 3100 potentiometer. Measurements were performed on all samples at each of the sampling times of the stability study.

Determination of total phenolic content (TPC)

Total phenolic content was determined using the Folin-Ciocalteu’s method with slight modifications (Mejia et al., 2020Mejia NM, Castro JP, Ocampo YC, Salas RD, Delporte CL, Franco LA. Evaluation of antioxidant potential and total phenolic content of exotic fruits grown in Colombia. J Appl Pharm Sci. 2020;10(09):050-8.). Briefly, 30 μL of different concentrations of the extracts under study were mixed with 150 μL of a Folin-Ciocalteu solution (0.1 M) and 120 μL of a sodium carbonate solution (7.5%). The mixture was incubated for 2 hours and the DO760 was determined in a microplate reader (Multiskan GO, Thermo). The results of TPC were presented as milligrams of gallic acid equivalent per gram of dry extract (mg GAE·g-1).

Effect on nitric oxide production and cell viability

RAW 264.7 macrophages were maintained routine in DMEM enriched with 10% inactivated FBS at 37 °C and 5% CO2. The effect on the release of nitric oxide (NO) was determined as a function of the accumulation of nitrites in the culture medium using the Griess reaction. Briefly, RAW 264.7 cells were plated in 96-well plates (2×104 cells/ well), incubated for 48 hours, and treated with the higher non-toxic concentration of A. peruviana extract. Thirty minutes later, cells were stimulated with LPS (1 μg/ml) and incubated for 24 h. Later, the medium was collected and stored at -20 ºC for the subsequent quantification of nitrite. To determine the effect on the viability, MTT solution (0.25 mg/mL) in fresh medium was added to the cells and incubated for 4 hours, after which the medium was carefully aspirated, and the resulting formazan crystals were dissolved in 100 μL of DMSO. Optical density (DO550) was determined using a microplate reader (Multiskan GO, Thermo), and the percentage of cell survival relative to the control group was calculated. NO concentration was determined by measuring the amount of nitrite in the cell culture supernatant using the Griess reaction (Green et al., 1982Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem. 1982;126(1):131-8.), equal volumes of Griess reactive and supernatants were mixed and the absorbance of samples was determined in a Multiskan GO microplate reader (DO550), the concentration of nitrites was calculated using a standard NaNO2 curve (1-200 μM). For all experiments, fresh culture medium was used as blank control, and 1400 W (10 μM), a selective inhibitor of iNOS, was used as positive control.

Compatibility study between the dry extract and excipients

Different binary mixtures of the dry extract of A. peruviana and excipients were evaluated to determine their compatibility. The excipients were selected considering a composition of a microemulsion formulation and their availability. Samples of 300 mg of dry extract were mixed with each one of the excipients at a 1:1 ratio. The excipients used were: oil phase castor oil, vegetable oil and coconut oil; surfactant sodium laureth sulfate; ceteareth-12; ceteareth-20; PEG-150 distearate; poloxamer 188; PEG-40 hydrogenated castor oil; cocamide DEA; oleth-5; PPG-1-PEG-9 lauryl glycol ether; PPG-5-laureth-5, PEG-35 castor oil; [PEG-7 coconutglycerides, PEG-40 hydrogenated castor oil, glycerin, and glyceryl oleate]; [MIPA-laureth sulfate, laureth-4 and cocamide DEA]; cosurfactant polysorbate 80; polyethylene glycol 400; glycerin and propylene glycol; poloxamer 407; antioxidant tocopherol and hydrogenated glycerides palm citrate; preserving agent benzyl alcohol, methylchloroisothiazolinone and methylisothiazolinone; stabilizing agent EDTA and vehicle (water).

The binary mixtures between the dry extract of A. peruviana and the required amount of excipient were placed in type I amber glass bottles. Finally, 20 mg of water (5%) were added to each of the samples and were mixed for 1 minute. to facilitate interactions between excipients and the extract. Subsequently, the samples were placed in a circulating air oven at a temperature of 50 °C for 15 days. As a negative control for degradation, the same procedure was carried out for the extract without excipients, placing a sample at 50 °C and another at 4 °C, to determine the true effect that excipients could have on degradation (Bernal, Ramos, Baena, 2019Bernal CA, Ramos FA, Baena Y. Dry powder formulation from Physalis peruviana L. fruits extract with antidiabetic activity formulated via co-spray drying. Int J Appl Pharm. 2019;11(3):109-17.; Kopelman, Augsburger, 2002Kopelman SH, Augsburger LL. Excipient compatibility study of Hypericum perforatum extract (St. John’s Wort) using similarity metrics to track phytochemical profile changes. Int J Pharm. 2002;237(1-2):35-46.; Serajuddin et al., 1999Serajuddin AT, Thakur AB, Ghoshal RN, Fakes MG, Ranadive SA, Morris KR, et al. Selection of solid dosage form composition through drug-excipient compatibility testing. J Pharm Sci. 1999;88(7):696-704.; Sims et al., 2003Sims JL, Carreira JA, Carrier DJ, Crabtree SR, Easton L, Hancock SA, et al. A new approach to accelerated drug-excipient compatibility testing. Pharm Dev Technol. 2003;8(2):119-26.; Wu et al., 2009Wu Y, Dali M, Gupta A, Raghavan K. Understanding drug-excipient compatibility: oxidation of compound A in a solid dosage form. Pharm Dev Technol. 2009;14(5):556-64.; Wyttenbach et al., 2005Wyttenbach N, Birringer C, Alsenz J, Kuentz M. Drug-excipient compatibility testing using a high-throughput approach and statistical design. Pharm Dev Technol. 2005;10(4):499-505.).

Upon completing the 15 days of study, each one of the samples was analyzed to find possible incompatibilities in the appearance and the compatibility was determined by evaluating the thermal behavior by means of DSC, in a Shimadzu DSC-60 equipment. During this process, they were subjected to heating starting with an approximate temperature of 25° C until reaching 200 °C, with a heating ramp of 10 °C/min. The samples were placed in an aluminum sample holder, covered, and hermetically sealed under a nitrogen atmosphere at a flow rate of 50 mL/min. The results were analyzed using the TA Analysis Software program.

Statistical analysis

Assay results of three independent experiments were expressed as the means±SEM and analyzed using one-way analysis of variance (ANOVA) with post-hoc Dunnet or Tukey comparison. P-values < 0.05 were considered statistically significant.

RESULTS AND DISCUSSION

Stability testing

Organoleptic characteristics

Dry seeds of Ambrosia peruviana were macerated with ethanol until 51.3 g of total extract (yield of 12.73%). The ethanolic extract of A. peruviana seeds showed dark green color as shown in Figure 1A, characteristic odour and appearance of viscous fluid, what makes handling difficult.

FIGURE 1
Ambrosia peruviana seeds dry extract.

Regarding the organoleptic characteristics observed at each time of the stability test under the different conditions, the extract that must keep under refrigeration (4 °C) or at room temperature (25 °C) had not significant changes; however, at 60 °C had slight changes in the color at the final of the study. In weeks 12 and 24 of the stability study, as shown the Figure 1B, the A. peruviana extract at 60ºC, presented dark brown coloration.

There are pigments in plants to which their coloration is attributed; among these could be found anthocyanins, carotenoids, and chlorophyll; the latter oversees providing the green coloration to the various plant species. However, the color can be affected by different factors such as light, pH, time, and temperature. Some authors indicated that the conversion of chlorophylls to pheophytins represents the main cause of the loss of green colour in plants. When they are subjected to heat or acidic conditions, said coloring of the vegetables turns into a brownish-green color (Ahmed, Kaur, Shivhare, 2002Ahmed J, Kaur A, Shivhare U. Color degradation kinetics of spinach, mustard leaves, and mixed puree. J Food Sci. 2002;67(3):1088-91.).

During the degradation process, hydronium ions can transform chlorophyll into pheophytin by substituting magnesium ions in the porphyrin ring. Figure 2 shows the degradation process of chlorophyll; when heating a plant extract, it may change in color to a brown-green that indicates the degradation of chlorophyll to pheophytin, which is subsequently degraded to pheophorbides which are brown compounds (Ahmed, Kaur, Shivhare, 2002Ahmed J, Kaur A, Shivhare U. Color degradation kinetics of spinach, mustard leaves, and mixed puree. J Food Sci. 2002;67(3):1088-91.).

FIGURE 2
Chemical degradation of chlorophylls. (Adapted from Rodríguez, Gallego, 1999Rodríguez MH, Gallego AS. Tratado de nutrición. Ediciones Díaz de Santos; 1999.).

pH

At the beginning of the stability test, the A. peruviana seed dry extract had a pH of 5.35 and was maintained at an interval of 5.2 to 5.6 as is observed in Figure 3. When these pH values obtained throughout the stability study were reviewed, no statistically significant differences were found between them at the different temperatures used and the different analysis times.

FIGURE 3
Changes of pH of the extract in the stability study.

Total phenolic content (TPC)

The Folin-Ciocalteu method was used to quantitatively determine phenolic compounds, based on the reaction of phenolic groups with the Folin-Ciocalteu reagent, a mixture of phosphomolybdate and phosphotungstate that forms the yellow phosphomolybdotungstate acid which, when it interacts with phenolic groups, reduces it causing a blue coloration. These blue pigments have a maximum absorption according to the quality and/or quantitative composition of phenolic mixtures in addition to the basic pH of the solution, which is generally obtained by adding sodium carbonate (Cicco et al., 2009Cicco N, Lanorte M, Paraggio M, Viggiano M, Lattanzio V. A reproducible, rapid and inexpensive Folin-Ciocalteu micro-method in determining phenolics of plant methanol extracts. Microchem J. 2009;91(1):107-10.). To determine the influence of the storage conditions on the A. peruviana seeds extract, the total phenolic content was evaluated at different temperatures and times, protecting the samples from light by using amber flasks to prevent this factor from having a significant influence on the extract.

The content of total phenolic compounds throughout the stability study shows that when evaluating the time at the stipulated storage conditions for the A. peruviana seeds dry extract, the degradation of these compounds is significant over 4 weeks (Figure 4). The extracts stored at 4°C and 25°C have similar behavior (reducing total polyphenols to 18.4 and 20.3%, respectively, of the initial concentration), while at 60 °C the decrease in phenols content in the extract is significantly greater (47.7%).

FIGURE 4
Changes of the total phenolic content in Ambrosia peruviana seeds extract during storage at different temperatures.

This behavior was previously described in extracts with high phenolic compound content, which presents a significant decrease in phenols after 30 days of storage at temperatures of 6 °C and 23 °C, which are close to those used for us in this assay. This is in addition to agreeing with the authors regarding the fact that the higher the temperature, the greater the reduction of total phenols in the extract (Srivastava et al., 2007Srivastava A, Akoh CC, Yi W, Fischer J, Krewer G. Effect of storage conditions on the biological activity of phenolic compounds of blueberry extract packed in glass bottles. J Agric Food Chem. 2007;55(7):2705-13.).

The presence of phenolic compounds in plants attribute antioxidant properties due to the ability to capture free radicals due to the presence of the hydroxyl group. However, the stability, biosynthesis, and degradation of this type of compounds can be affected by various factors such as storage conditions and light that can negatively influence the quantity of phenolic compounds present in the plant (Lattanzio, 2003Lattanzio V. Bioactive polyphenols: their role in quality and storability of fruit and vegetables. J Appl Bot. 2003;77(5/6):128-46.; Valenzuela et al., 2014Valenzuela GM, Cravzov AL, Soro AS, Tauguinas AL, Giménez MC, Gruszycki MR. Relación entre actividad antioxidante y contenido de fenoles y flavonoides totales en semillas de Cucurbita spp. Dominguezia. 2014;30(1):19-24.).

The Folin-Ciocalteu method is widely used to determine the effect of the storage conditions due to the possibility that some of the degradation products could react with the Folin-Ciocalteu reagent, affecting the content of phenolic compounds (Camelo, Sotelo, 2012Camelo G, Sotelo L. Efecto de las condiciones de almacenamiento sobre el color, contenido de polifenoles y capacidad antioxidante de una bebida de Borojoa patinoi Cuatrecasas. Boletin Latinoam Caribe Plantas Med Aromat. 2012;11(2):196-205.). In plant species, in addition to bioactive compounds, there are also enzymes such as polyphenol oxidases (PFOs), which are metalloenzymes present in the different organs of plants (roots, seeds, leaves and fruits) and which are responsible for the oxidative degradation of polyphenols, also called enzymatic browning.

The degradation of phenolic compounds by enzymatic oxidation or enzymatic browning may partially explain the change in the color of the extract under heat stress conditions, as phenolic compounds oxidize and polymerize to a brown color (Morante et al., 2014Morante J, Agnieszka A, Bru R, Carranza M, Pico R, Nieto E. Distribución, localización e inhibidores de las polifenol oxidasas en frutos y vegetales usados como alimento. Cienc Tecnol. 2014;7(1):23-31.). On the other hand, the possibility of simultaneous degradation of the phenolic and chlorophyll yielding a color change of the extract from dark green to brown can not be ruled out; Regarding the influence of temperature and exposure time on the stability of phenols, significant degradation was observed at high temperatures (60 °C), which increased with exposure time in this condition (12 and 24 weeks). Other authors have already observed this relationship between exposure time and temperature in the degradation of bioactive constituents (Camelo, Sotelo, 2012Camelo G, Sotelo L. Efecto de las condiciones de almacenamiento sobre el color, contenido de polifenoles y capacidad antioxidante de una bebida de Borojoa patinoi Cuatrecasas. Boletin Latinoam Caribe Plantas Med Aromat. 2012;11(2):196-205.; Uurrea et al., 2012Uurrea D, Eim V, Roselló C, Simal S. Modelos cinéticos de degradación de carotenoides, polifenoles y actividad antioxidante durante el secado convectivo de zanahoria (Daucus carota V. Nantesa). Aliment Hoy. 2012;21(27):68-101.), corroborating the close relationship between them.

Biological evaluation

The Griess method is a colorimetric test by which organic nitrites are detected. It is carried out using two solutions (A and B). Reagent A consists of sulfanilamide with the addition of a strong acid and reagent B of N (1-naphthyl) ethylenediamine. (Malinski, Mesaros, Tomboulian, 1996Malinski T, Mesaros S, Tomboulian P. Nitric oxide measurement using electrochemical methods. Methods Enzymol. 1996;268:58-69.). The Griess reaction is based on the formation of azo dyes. The test consists of two reactions, which result in the formation of a colored reagent. In the first reaction the nitrite reacts with sulfanilamide under acid conditions (diazotization reaction) and at the second stage a diazotization product reacts with N-(1-naphthyl) ethylenediamine (diazonium coupling) to form an azo derivative dye. This azo derivative is readily quantifiable by means of a spectrophotometer. Due to its simplicity, speed and satisfactory sensitivity, the Griess reaction has become a widely used colorimetric method for the determination of nitrite in various matrices (Malinski, Mesaros, Tomboulian, 1996Malinski T, Mesaros S, Tomboulian P. Nitric oxide measurement using electrochemical methods. Methods Enzymol. 1996;268:58-69.).

The biological activity shown by the extract of A. peruviana (15 μg/mL) was conserved during the time of the stability study for the temperatures of 4 ºC and 25 ºC, while the extract subjected to high temperatures (60ºC) showed a significant reduction of the inhibition of NO production in macrophages which is evident from 8 weeks where the inhibition of nitric oxide production has decreased more than 50% (Figure 5).

FIGURE 5
Inhibition of NO production by Ambrosia peruviana seed extract during storage at different temperatures for 24 weeks.

Macrophages play a critical role in the immune response, its activation with LPS releases large amounts of nitrites which are essential precursors of cytotoxic agents (Hibbs, Vavrin, Taintor, 1987Hibbs JB, Vavrin Z, Taintor RR. L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J Immunol. 1987;138(2):550-65.; Nathan, 1992Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 1992;6(12):3051-64.). The excessive production of NO by macrophages during a chronic inflammatory response causes disturbance in essential molecules such as membrane lipids, nucleic acids, proteins, which leads to oxidative stress affecting cellular homeostasis. Hence, the development of products that have substances to prevent the overproduction of NO has become the objective of research to treat chronic inflammation (Desai, Park, 2005Desai KGH, Park HJ. Recent developments in microencapsulation of food ingredients. Dry Technol. 2005;23(7):1361-94.; Taira, Nanbu, Ueda, 2009Taira J, Nanbu H, Ueda K. Nitric oxide-scavenging compounds in Agrimonia pilosa Ledeb on LPS-induced RAW264. 7 macrophages. Food Chem. 2009;115(4):1221-7.).

Compatibility study between the dry extract and excipients

Figure 6 shows the thermogram of the extract stored at different temperatures (4 and 50 °C). In these curves, two endothermic transitions were detected between approximately 130 and 150 °C. It is generally said that natural products whose composition consists of a great variety of substances, such as the extract under study, present similar thermal behavior (Bernal, Aragón, Baena, 2016Bernal CA, Aragón M, Baena Y. Dry powder formulation from fruits of Physalis peruviana L. standardized extract with hypoglycemic activity. Powder Technol. 2016;301:839-47., 2019). It should be noted that this behavior is maintained at both temperatures, with the difference that at 50 °C the endothermic transitions are smaller in size compared to what is observed at 4 °C, concluding that the storage temperature influences the thermal behavior of the extract but not significantly.

FIGURE 6
DSC curves of Ambrosia peruviana seeds extract stored at different temperatures.

However, the aim is to incorporate the extract into a microemulsion, therefore, a series of excipients were selected according to the chosen pharmaceutical form, hoping that when mixing with the extract the thermal behaviors of both would be maintained, indicating that they are compatible and that therefore both it is possible to use them in a formulation (Uurrea et al., 2012Uurrea D, Eim V, Roselló C, Simal S. Modelos cinéticos de degradación de carotenoides, polifenoles y actividad antioxidante durante el secado convectivo de zanahoria (Daucus carota V. Nantesa). Aliment Hoy. 2012;21(27):68-101.).

The thermal behavior of the extract, the respective excipient and the extract-excipient combination are compared in the DSC curves. For them to be considered to be compatible, the thermal behavior of the extract and the excipient in question must be maintained. The example in Figure 7 shows the thermal behavior of the extract, the excipient 1 (Castor Oil) which is highly thermostable as it does not present peaks, and the combination of both, from which it can be said that castor oil is compatible with the extract, because the mixture maintains the two endothermic transitions characteristic of the extract, and that in this case the excipient that does not present thermal transitions in this temperature range. It does not alter the behavior of the extract when mixed with it.

FIGURE 7
DSC curves of Ambrosia peruviana seed extract and castor oil (excipient #1).

After carrying out the analysis of the different thermograms of the mixtures and comparing them with the thermal behavior that the extract and the excipient presented separately, it was found that within the working conditions used during the study by DSC there is no chemical incompatibility between the extract of A. peruviana seeds and a large part of the selected excipients, (Data not shown). Here the thermal behavior of the components is maintained separately or they suffer variations such as widening or displacement of endothermal peaks, which are not significant since this type of phenomenon can be typical of the decrease in the purity of each component due to the mixture (Kiss et al., 2006Kiss D, Zelkó R, Novák Cs, Éhen Zs. Application of DSC and NIRS to study the compatibility of metronidazole with different pharmaceutical excipients. J Therm Anal Calorim. 2006;84(2):447-51.; Ranjan et al., 2012Ranjan N, Kanta L, Acharya S, Bhuniya B. Application of DSC, IST, and FTIR study in the compatibility testing of nateglinide with different pharmaceutical excipients. J Therm Anal Calorim. 2012;108(1):219-26.).

As an example of interactions, Figure 8 shows the thermogram of the extract and excipient 4 (sodium lauryl ether sulfate) which presents an endothermic peak between approximately 100 and 120 ° C and that when mixed with the extract, the disappearance of this thermal peak is observed, which may indicate a possible interaction among them. Nevertheless, when observing the thermograms of excipients 2, 4, 5, 12, 14, 16, and 20 (Data not shown), it is possible to appreciate marked differences in the mixture curve, which probably lead to interactions among them. These differences may be due to various factors, among which we find the disappearance or appearance of peaks in the curves, due to possible chemical extract-excipient interactions when the mixture is heated.

FIGURE 8
DSC curves of Ambrosia peruviana seed extract and sodium laureth sulfate (excipient #4).

It should also be noted that in some of the mixtures previously mentioned as incompatible, there are significant widening and displacement of the peaks of both the extract and the excipient. Said thermal behavior may indicate an alteration in the characteristic of some of the components, and that could compromise the stability and pharmacological activity of the extract. However, most excipients turn out to be compatible for this reason; it can be said that they are considered potential candidates to be included in microemulsion formulations that contain the extract of A. peruviana seeds. The results of the excipient compatibility are shown in the Table II.

TABLE II
Results of the excipient compatibility evaluated by DSC

CONCLUSION

The preformulation studies of the ethanolic extract from seeds of Ambrosia peruviana all suggested it was stable at temperatures of 4 °C and 25 °C during the 24 weeks, presenting losses of approximately 21% of the initial phenolic content. On the other hand, it was unstable at 60 °C losing approximately 50% of the initial phenolic content after 12 weeks. Moreover, the anti-inflammatory effect evaluated on nitric oxide production and cell viability demonstrated the excellent activity of the extract, which did not change at 4 °C and 25 °C.

The compatibility study among the dry extract and excipients showed that the extract was compatible against different excipients: oils, surfactants, cosurfactants, antioxidants, preserving agents, stabilizing agents, and vehicles. This study is the first step for formulating Ambrosia peruviana seeds ethanolic extract as a standardized microemulsion dosage form.

ACKNOWLEDGEMENTS

The authors acknowledge the Research Division of Universidad de Cartagena (Project Code: 109-2018) for the financial support of this work and the Programa de Pós-graduação em Ciências Farmacêuticas, Universidade Federal do Rio Grande do Sul, Brazil for hosting C.B.R. as a visiting researcher where part of this research was developed.

REFERENCES

  • Ahmed J, Kaur A, Shivhare U. Color degradation kinetics of spinach, mustard leaves, and mixed puree. J Food Sci 2002;67(3):1088-91.
  • Andrade MG. Estado del conocimiento de la biodiversidad en Colombia y sus amenazas. Consideraciones para fortalecer la interacción ciencia-política. Rev Acad Colomb Cienc Exactas Fis Nat 2011;35(137):491-508.
  • Bernal CA, Aragón M, Baena Y. Dry powder formulation from fruits of Physalis peruviana L. standardized extract with hypoglycemic activity. Powder Technol 2016;301:839-47.
  • Bernal CA, Ramos FA, Baena Y. Dry powder formulation from Physalis peruviana L. fruits extract with antidiabetic activity formulated via co-spray drying. Int J Appl Pharm 2019;11(3):109-17.
  • Camelo G, Sotelo L. Efecto de las condiciones de almacenamiento sobre el color, contenido de polifenoles y capacidad antioxidante de una bebida de Borojoa patinoi Cuatrecasas. Boletin Latinoam Caribe Plantas Med Aromat 2012;11(2):196-205.
  • Castro JP, Franco LA, Diaz F. Anti-inflammatory screening of plant species from the Colombian Caribbean Coast. J Appl Pharm Sci 2021;11(04):106-17.
  • Cicció JF, Chaverri C. Essential oil composition of Ambrosia cumanensis (Asteraceae) from Costa Rica. Am J Essent Oils Nat Prod 2015;3(2):15-21.
  • Cicco N, Lanorte M, Paraggio M, Viggiano M, Lattanzio V. A reproducible, rapid and inexpensive Folin-Ciocalteu micro-method in determining phenolics of plant methanol extracts. Microchem J 2009;91(1):107-10.
  • Desai KGH, Park HJ. Recent developments in microencapsulation of food ingredients. Dry Technol 2005;23(7):1361-94.
  • Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 1982;126(1):131-8.
  • Hibbs JB, Vavrin Z, Taintor RR. L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J Immunol 1987;138(2):550-65.
  • ICH. Harmonised tripartite guideline, stability testing of new drug substances and products, Q1A(R2) Geneva, Switzerland: ICH; 2003.
  • Jimenez-Usuga NDS, Malafronte N, Cotugno R, De Leo M, Osorio E, De Tommasi N. New sesquiterpene lactones from Ambrosia cumanensis Kunth. Fitoterapia 2016;113:170-4.
  • Kingston DG. Modern natural products drug discovery and its relevance to biodiversity conservation. J Nat Prod 2010;74(3):496-511.
  • Kiss D, Zelkó R, Novák Cs, Éhen Zs. Application of DSC and NIRS to study the compatibility of metronidazole with different pharmaceutical excipients. J Therm Anal Calorim 2006;84(2):447-51.
  • Kopelman SH, Augsburger LL. Excipient compatibility study of Hypericum perforatum extract (St. John’s Wort) using similarity metrics to track phytochemical profile changes. Int J Pharm 2002;237(1-2):35-46.
  • Lattanzio V. Bioactive polyphenols: their role in quality and storability of fruit and vegetables. J Appl Bot 2003;77(5/6):128-46.
  • Malinski T, Mesaros S, Tomboulian P. Nitric oxide measurement using electrochemical methods. Methods Enzymol 1996;268:58-69.
  • Matiz G, Cárdenas P, Rincon V. Estudios de preformulación de un fitomedicamento tópico antiinflamatorio con base en fracciones activas de flores y hojas de Caesalpinia pulcherrima (L.) Swartz empleando modelos analíticos biológicos. Lat Am J Pharm 2007;26(3):332.
  • Medzhitov R. Origin and physiological roles of inflammation. Nature 2008;454(7203):428-35.
  • Meetoo D. Chronic diseases: the silent global epidemic. Br J Nurs 2008;17(21):1320-5.
  • Mejia NM, Castro JP, Ocampo YC, Salas RD, Delporte CL, Franco LA. Evaluation of antioxidant potential and total phenolic content of exotic fruits grown in Colombia. J Appl Pharm Sci 2020;10(09):050-8.
  • Morante J, Agnieszka A, Bru R, Carranza M, Pico R, Nieto E. Distribución, localización e inhibidores de las polifenol oxidasas en frutos y vegetales usados como alimento. Cienc Tecnol 2014;7(1):23-31.
  • Nagai J, Uesawa Y, Shimamura R, Kagaya H. Characterization of the adverse effects induced by acetaminophen and nonsteroidal anti-inflammatory drugs based on the analysis of the japanese adverse drug event report database. Clin J Pain 2017;33(8):667-75.
  • Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992;6(12):3051-64.
  • Organización Mundial de la Salud (OMS), Estrategias de la OMS sobre medicina tradicional 2014-2023 Ginebra; 2013.
  • Pan MH, Lai CS, Ho CT. Anti-inflammatory activity of natural dietary flavonoids. Food Funct 2010;1(1):15-31.
  • Prasad S, Sung B, Aggarwal BB. Age-Associated chronic diseases require age-old medicine: role of chronic inflammation. Prev Med 2012;54(Suppl):S29-37.
  • Ranjan N, Kanta L, Acharya S, Bhuniya B. Application of DSC, IST, and FTIR study in the compatibility testing of nateglinide with different pharmaceutical excipients. J Therm Anal Calorim 2012;108(1):219-26.
  • Rodríguez MH, Gallego AS. Tratado de nutrición Ediciones Díaz de Santos; 1999.
  • Serajuddin AT, Thakur AB, Ghoshal RN, Fakes MG, Ranadive SA, Morris KR, et al. Selection of solid dosage form composition through drug-excipient compatibility testing. J Pharm Sci 1999;88(7):696-704.
  • Sims JL, Carreira JA, Carrier DJ, Crabtree SR, Easton L, Hancock SA, et al. A new approach to accelerated drug-excipient compatibility testing. Pharm Dev Technol 2003;8(2):119-26.
  • Srivastava A, Akoh CC, Yi W, Fischer J, Krewer G. Effect of storage conditions on the biological activity of phenolic compounds of blueberry extract packed in glass bottles. J Agric Food Chem 2007;55(7):2705-13.
  • Taira J, Nanbu H, Ueda K. Nitric oxide-scavenging compounds in Agrimonia pilosa Ledeb on LPS-induced RAW264. 7 macrophages. Food Chem 2009;115(4):1221-7.
  • Uurrea D, Eim V, Roselló C, Simal S. Modelos cinéticos de degradación de carotenoides, polifenoles y actividad antioxidante durante el secado convectivo de zanahoria (Daucus carota V. Nantesa). Aliment Hoy 2012;21(27):68-101.
  • Valenzuela GM, Cravzov AL, Soro AS, Tauguinas AL, Giménez MC, Gruszycki MR. Relación entre actividad antioxidante y contenido de fenoles y flavonoides totales en semillas de Cucurbita spp. Dominguezia 2014;30(1):19-24.
  • Vonkeman HE, Van de Laar MAFJ. Nonsteroidal anti-inflammatory drugs: adverse effects and their prevention. Semin Arthritis Rheum 2010;39(4):294-312.
  • WHO. WHO Expert Committee on specifications for pharmaceutical preparations. Rev Inst Med Trop São Paulo 2008;50(3):144-144.
  • Wu Y, Dali M, Gupta A, Raghavan K. Understanding drug-excipient compatibility: oxidation of compound A in a solid dosage form. Pharm Dev Technol 2009;14(5):556-64.
  • Wyttenbach N, Birringer C, Alsenz J, Kuentz M. Drug-excipient compatibility testing using a high-throughput approach and statistical design. Pharm Dev Technol 2005;10(4):499-505.

Publication Dates

  • Publication in this collection
    22 May 2023
  • Date of issue
    2023

History

  • Received
    01 July 2022
  • Accepted
    11 Sept 2022
Universidade de São Paulo, Faculdade de Ciências Farmacêuticas Av. Prof. Lineu Prestes, n. 580, 05508-000 S. Paulo/SP Brasil, Tel.: (55 11) 3091-3824 - São Paulo - SP - Brazil
E-mail: bjps@usp.br